| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Division of Endocrinology and Metabolism (D.P.O., R.J.K.), University of Michigan Medical Center, Ann Arbor, Michigan 48109-0678
Address all correspondence and requests for reprints to: Dr. Ronald J. Koenig, University of Michigan Medical Center, 5560 MSRB-2, 1150 West Medical Center Drive, Ann Arbor, Michigan 48109-0678. E-mail: rkoenig{at}umich.edu
Rubinstein-Taybi syndrome (RTS) is a genetic syndrome characterized by broad thumbs and halluces, growth retardation, mental retardation, and craniofacial abnormalities. This condition recently was found to be caused by mutations in the gene encoding cAMP response element-binding protein (CREB)-binding protein. As CREB-binding protein has been shown to be a critical coactivator for thyroid hormone receptors, it is plausible that RTS would be characterized by thyroid hormone resistance. In fact, features of RTS, such as mental retardation and short stature, are consistent with thyroid hormone deficiency or resistance. To assess the function of the thyroid axis in RTS, free T4 and TSH were measured in 12 subjects with this syndrome. The free T4 level was normal in all 12 (mean ± SD, 0.97 ± 0.20 ng/dL; normal range, 0.731.79), as was the TSH level (2.24 ± 0.87 µU/mL; normal range, 0.36.5). Thus, overt thyroid hormone resistance does not appear to be a typical feature of RTS.
This article has been cited by other articles:
![]() |
M. Kishimoto, Y. Okimura, K. Yagita, G. Iguchi, M. Fumoto, K. Iida, H. Kaji, H. Okamura, and K. Chihara Novel Function of the Transactivation Domain of a Pituitary-specific Transcription Factor, Pit-1 J. Biol. Chem., November 15, 2002; 277(47): 45141 - 45148. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Goodman and S. Smolik CBP/p300 in cell growth, transformation, and development Genes & Dev., July 1, 2000; 14(13): 1553 - 1577. [Full Text] |
||||
![]() |
M. Anafi, Y.-F. Yang, N. A. Barlev, M. V. Govindan, S. L. Berger, T. R. Butt, and P. G. Walfish GCN5 and ADA Adaptor Proteins Regulate Triiodothyronine/GRIP1 and SRC-1 Coactivator-Dependent Gene Activation by the Human Thyroid Hormone Receptor Mol. Endocrinol., May 1, 2000; 14(5): 718 - 732. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |